Jeff Yass’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-55,066
| Closed | -$348K | – | 14064 |
|
|
2022
Q4 | $348K | Sell |
55,066
-51,670
| -48% | -$286K | ﹤0.01% | 8739 |
|
|
2022
Q3 | $546K | Sell |
106,736
-41,198
| -28% | -$259K | ﹤0.01% | 8253 |
|
|
2022
Q2 | $926K | Buy |
+147,934
| New | +$498K | ﹤0.01% | 6721 |
|
|
2022
Q1 | – | Sell |
-14,251
| Closed | -$72K | – | 14376 |
|
|
2021
Q4 | $72K | Buy |
+14,251
| New | +$85.9K | ﹤0.01% | 12361 |
|
|
2019
Q3 | – | Sell |
-6,171
| Closed | -$91K | – | 11044 |
|
|
2019
Q2 | $91K | Buy |
+6,171
| New | +$165K | ﹤0.01% | 9647 |
|
|
2018
Q3 | – | Sell |
-3,870
| Closed | -$183K | – | 10530 |
|
|
2018
Q2 | $183K | Sell |
3,870
-5,649
| -59% | -$313K | ﹤0.01% | 8696 |
|
|
2018
Q1 | $586K | Buy |
+9,519
| New | +$502K | ﹤0.01% | 6305 |
|
|
2017
Q1 | – | Sell |
-27,411
| Closed | -$876K | – | 10267 |
|
|
2016
Q4 | $876K | Buy |
+27,411
| New | +$1M | ﹤0.01% | 5813 |
|
Jeff Yass's FSTX Position: Q1 2023 in Review
Jeff Yass sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 55,066 shares — an estimated $348K sold.
Jeff Yass first reported a position in FSTX in Q4 2016 and held it in 8 quarters. The position peaked at $926K in Q2 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Jeff Yass reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Jeff Yass sold 55,066 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $348K.
- Jeff Yass first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2016 and held it in 8 quarters.
- Jeff Yass's F-star Therapeutics, Inc. Common Stock position peaked at $926K in Q2 2022.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.